MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation.
about
Organ allocation for chronic liver disease: model for end-stage liver disease and beyondMolecular prognostic prediction in liver cirrhosisModel for End-stage Liver DiseaseOutcomes of liver transplantation in patients with hepatorenal syndromeProtecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.Reversal of hepatorenal syndrome type 1 with terlipressin plus albumin vs. placebo plus albumin in a pooled analysis of the OT-0401 and REVERSE randomised clinical studies.Current concepts in the diagnosis and classification of renal dysfunction in cirrhosis.Longitudinal assessment of prognostic factors for patients with hepatorenal syndrome in a tertiary centerSerum microRNA-122 predicts survival in patients with liver cirrhosis.Management of cirrhotic ascitesTherapy insight: Management of hepatorenal syndrome.A pilot study to evaluate renal hemodynamics in cirrhosis by simultaneous glomerular filtration rate, renal plasma flow, renal resistive indices and biomarkers measurements.Hepatorenal syndrome: aetiology, diagnosis, and treatment.Renal impairment in cirrhosis unrelated to hepatorenal syndromeImproving survival in decompensated cirrhosisSerelaxin as a potential treatment for renal dysfunction in cirrhosis: Preclinical evaluation and results of a randomized phase 2 trial.Intravenous albumin for the prevention of contrast-induced nephropathy in patients with liver cirrhosis and chronic kidney disease undergoing contrast-enhanced CT.Model for end-stage liver disease: end of the first decade.Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.Hyponatremia and Hepatorenal SyndromeHepatorenal syndrome:Response to terlipressin and albumin and its determinants.A randomized, prospective, double-blind, placebo-controlled trial of terlipressin for type 1 hepatorenal syndromeImpact of liver transplantation on the survival of patients treated for hepatorenal syndrome type 1.Risk of contrast-induced nephropathy in hospitalized patients with cirrhosis.Acute kidney injury in cirrhosis.Clinical course and prognostic factors of hepatorenal syndrome: A retrospective single-center cohort study.Terlipressin in hepatorenal syndrome: a systematic review and meta-analysisPerformance of chronic kidney disease epidemiology collaboration creatinine-cystatin C equation for estimating kidney function in cirrhosis.Three-dimensional conformal radiotherapy for locally advanced hepatocellular carcinoma with portal vein tumour thrombosis: evaluating effectiveness of the model for end-stage liver disease (MELD) score compared with the Child-Pugh classification.A single center experience of combined liver kidney transplantation.Clinical applications of the Model for End-Stage Liver Disease (MELD) in hepatic medicine.Acute kidney injury is independently associated with death in patients with cirrhosis.Urinary neutrophil gelatinase-associated lipocalin predicts mortality and identifies acute kidney injury in cirrhosis.Accuracy of MELD scores in predicting mortality in decompensated cirrhosis from variceal bleeding, hepatorenal syndrome, alcoholic hepatitis, or acute liver failure as well as mortality after non-transplant surgery or TIPS.Hepatorenal syndrome in the intensive care unit.Serum markers for predicting abdominal surgery outcomes in patients with cirrhosis.Cirrhotic ascites review: Pathophysiology, diagnosis and management.Important predictor of mortality in patients with end-stage liver disease.Beyond a broken heart: circulatory dysfunction in the failing Fontan.Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation.
P2860
Q24633350-25B21A3F-F1CD-4F7E-880A-BC0F486CD843Q26784251-A588DE62-3892-4FA0-A612-149EAEB89777Q26864971-92645FC8-A79F-4E48-B43F-925747877F29Q28068506-A9A15846-A4C9-41EF-849C-5FFE57B208EFQ30251763-55AAB4F7-04B5-46FE-9CDC-2D556CFD97BFQ33698303-F8FC698A-2635-4660-B925-14C6560B6D9CQ33811643-4C0C26C6-910A-4B5E-B15F-B2859FBCF6EAQ33977165-6BAF279E-7979-4690-83F7-739D22FE1564Q34429711-D7573AE6-B70E-4546-BF0D-32BCA2A732D0Q34475601-616AF072-06BE-43C1-AAFA-B3DED1AE9F69Q34533221-4F373C06-AF36-4012-9493-9F89F7E13B53Q34873261-4D8E70D9-2EAC-44B7-9359-4A30E60BD866Q35012890-D4B432DE-A0C4-49AF-82D9-1473139B0D97Q35742662-F13EFC30-DAE8-4ABE-B694-B1B8D96ED775Q36090423-322A56FD-793B-4E7C-89FC-D822422F4A98Q36292811-DC4B70E3-BC59-4F57-BC49-D1F4C057BA39Q36468598-B9BA5A8A-95D7-4656-A014-574859927306Q36588122-435D7235-5723-4722-A935-2F4A796ED7E5Q36772257-9EC87056-7CFE-4339-8ACE-FCF523BD358EQ36812531-971E5F41-0313-47F9-8A91-FFEC0B45E0D0Q36876331-CDE5C6D8-66E5-4683-829E-5B93CD3925E9Q37061659-C1A89954-DDC6-43A7-8651-A7B85356C6BCQ37141412-F22C183F-D409-4BEB-86A9-A68EB1209967Q37149577-971E94BD-80CC-4125-B218-34596DA7C43EQ37323711-E5E53E0F-9B07-4982-BE9E-CCE14677C670Q37429032-A0FA4078-4641-40AB-A321-2CE182727A0BQ37438171-FB1517F7-3CED-4E8F-B2F2-8EC9BAB351CBQ37445605-9824D82F-AAD2-4E53-AEBE-B488FE8FC112Q37600883-760101DA-05EE-4599-AEC0-7E7D02D72F05Q37636489-BA406326-9BAA-4ECF-B595-B885EA3CCC0BQ37636499-E816CF45-F311-4CD0-AD01-8F139CC19CE7Q37640362-05EBDA25-D276-43D4-8788-BFEDC97FC1F7Q37691475-04DFA9AC-D985-47D3-90E0-6A39EB842C1FQ37789176-848DF76F-F465-4DD2-9BBE-B7E99FBFDEC4Q37920945-3DAFE514-2B3E-4567-9272-737B5D8DC45CQ38080748-CE3635E3-6843-4A11-B74E-2CF2B13A2C11Q38110291-A423D9CA-8A0A-4796-86D0-3A0334F27104Q38120248-158E65BE-54DA-4D02-AC78-E04CA6F1CB12Q38188461-418E0FAD-DC60-46E8-91F7-D9BCAED2B9E1Q38271183-AC609E43-3851-4D73-82EE-B2CD8A2760F9
P2860
MELD score and clinical type predict prognosis in hepatorenal syndrome: relevance to liver transplantation.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
MELD score and clinical type p ...... ance to liver transplantation.
@ast
MELD score and clinical type p ...... ance to liver transplantation.
@en
type
label
MELD score and clinical type p ...... ance to liver transplantation.
@ast
MELD score and clinical type p ...... ance to liver transplantation.
@en
prefLabel
MELD score and clinical type p ...... ance to liver transplantation.
@ast
MELD score and clinical type p ...... ance to liver transplantation.
@en
P2093
P50
P356
P1433
P1476
MELD score and clinical type p ...... ance to liver transplantation.
@en
P2093
Carlo Alessandria
Juan Rodés
Mónica Guevara
Osman Ozdogan
Tea Restuccia
P2860
P304
P356
10.1002/HEP.20687
P407
P577
2005-06-01T00:00:00Z